Back to video list Back to Home Can you comment on cardiovascular safety of CGRP pathway monoclonal antibody? You may also like Alzheimer's Disease Congress highlights Article Predicting dementia based on mild cognitive impairment and biomarkers Schizophrenia Congress highlights Article What can be done for patients with primary psychosis to achieve recovery? Alzheimer's Disease Article Alzheimer’s disease in 2021 & beyond – Where we are now Alzheimer's Disease Article Mild Behaviour Impairment (MBI) as a Potential Early Marker for Dementia